Camanio Care AB (publ) issues free warrants to all shareholders

Care Camanio Care AB has signed an agreement relating to an investment of up to SEK 20 million. In connection with the Agreement, Camanio Care will also issue free warrants to existing shareholders, to protect them against equity dilution (the “Shareholders Warrants”). 

The agreement and it’s terms was communicated in a press message on December 6th. The first Tranche is a private placement of SEK 4 million launched under the agreement.

For the first Tranche, one (1) warrant will be allocated for every seventeenth (17) shares that is held at the closing of stock exchange on Dec 22nd 2017.

Last day for trade in Camanio Care share including the right to receive Shareholder warrants is December 20th 2017.

Allocation of the shareholders warrants will take place on Dec 28th 2017 through EuroClear that manages Camanio Cares share register.

The Warrants have a maturity of three (3) years from Dec.13th 2017, when the registration was completed at the Swedish Companies Registration Office (Bolagsverket).

The Shareholders Warrants will have the same characteristics as those of the Investor will together be admitted to trading on AktieTorget.

In the specific case of the first Tranche, the strike price will be SEK 3.20. Under this first Tranche, there are 625,000 Warrants issued to the Investor and 907,770 Shareholders’ Warrants.

Subscription and Exercising the Shareholders’ Warrants:

Subscription of new shares by exercising the warrants of a collected value of 500 000 SEK or more can take place at any time during the maturity period (eg any day during the 3-year period).

Subscription of new shares by exercising the warrants of a collected value of 500 000 SEK or less can only take place at six occasions during the two-week period before 6, 12, 18, 24, 30 or 36 months (each month is calculated as four (4) weeks) after Dec.13th 2017 den 13 december 2017 when the registration was completed at the Swedish Companies Registration Office (Bolagsverket).

The first of these six occasions takes place during May 16th 2018 until May 30th 2018.

The full terms and conditions of the Notes, the Warrants and the Shareholders' Warrants will be published on Camanio Care's website within soon.

For further information, please contact:

Catharina Borgenstierna, CEO
Telephone: 0733-93 00 07

About Camanio Care

Camanio Care is a company operating in the caretech marketplace with robotics, assistive devices and gamification that focus on supporting basic human needs. We provide products and services that improve quality and efficiency in the areas of Active Life, Mealtime Situation and Digital Care with products such as BikeAroundTM, Giraff and Bestic®. Camanio Care has its headquarters in Stockholm, Sweden, subsidiaries in the USA and distributors in ten European countries and also Australia and China. We make the future work!

Subscribe to our newsletter and/or read more about us, Camanio Care at:

This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, on December 15th, 2017. 

About Us

Camanio Care is a care tech company that develops innovative solutions for a good care at home with the individual in focus. Camanio Care offers digital service platforms for digital care, robotics, assistive devices and gamification, with products such as VITAL, BikeAround ™, Bestic® and Giraff ™.Through three focus areas; Activation, Mealtime and Digital care, Camanio Care wishes to support people's basic needs and increase accessibility and quality within health care. Camanio Care AB today has its headquarters in Stockholm, a US subsidiary, Camanio Care Inc., as well as distributors in Asia, the Middle East, Hong Kong, Australia and in ten European countries.


Documents & Links